Company / Goodwill
Biogen Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$6.5B
FY2025
5-year range
$5.7B / $6.5B
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#11 of 76
Health Care
What the data says
Biogen's goodwill of $6.5B is higher than 86% of companies in the Health Care sector (FY2025). Goodwill has increased for 3 consecutive years, from $5.7B in FY2022 to $6.5B in FY2025.
Based on SEC 10-K filings.
$6.5B in FY2025 with a 5-year CAGR of +2.4%. Top quartile in the Health Care sector.
Improved from $6.2B to $6.5B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +4.1%
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 76This company $6.5B Sector average $3.9B
▼
+65.7% above sector average
Key checks
Key Insights
- Biogen's goodwill has grown for 3 consecutive years.
- 5-year CAGR of +2.4%, indicating consistent growth.
- In FY2025, goodwill increased 0.2% year-over-year.
- Ranks #11 out of 76 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.5B | +0.2% |
| FY2024 | $6.5B | +4.2% |
| FY2023 | $6.2B | +8.2% |
| FY2022 | $5.7B | -0.2% |
| FY2021 | $5.8B | -0.0% |
| FY2020 | $5.8B | +0.1% |
| FY2019 | $5.8B | +0.9% |
| FY2018 | $5.7B | +23.2% |
| FY2017 | $4.6B | +26.3% |
| FY2016 | $3.7B | +37.7% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026